Skip to main content
. 2014 Mar;35(3):524–528. doi: 10.3174/ajnr.A3707

Table 6:

Complications of systemic (IV) thrombolysis and endovascular (intra-arterial) treatment

Trial Symptomatic ICH SAH
NINDS 6.4% 0%
PROACT I 15.4% na
PROACT II 10.2% na
IMS I 6.3% 0%
IMS II 9.9% na
Merci 7.8% 3.5%
Multi-Merci 9.8% 9.9%
Penumbra 10% 5%
SWIFT-all 4.9% 7.6%
SWIFT-Merci arm 10.9% 12.7%
SWIFT-Solitaire arm 1.1% 4.5%